Thompson G K, Stevens L M, Anderson J P. "一种的合成方法" [P]. US Patent, US 10422289 B2, 2019-06-12.
Chen K W, Patel M V, Hughes D C. "Method for the Synthesis of Methyl(([3-(oxan-4-yl)-1,2,4-oxadiazol-5-yl]methyl))amine" [P]. US Patent, US 10295359 B2, 2019-02-25.
发明人郑宇鹏,黄志刚,杨光. "A Process for Preparing High-Purity Methyl(([3-(oxan-4-yl)-1,2,4-oxadiazol-5-yl]methyl))amine" [P]. 中国发明专利, 专利号 CN 115374096 B, 授权公告日 2017-01-12.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Sci. Total Environ., 2015, 1480, (5), 8395-8407.
Yang F, Sun W, Liu J. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2014, 1622, (5), 2405-2408.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Methyl(([3-(oxan-4-yl)-1,2,4-oxadiazol-5-yl]methyl))amine Using HRMS and NMR". Biomed. Chromatogr., 2015, 1555, (10), 990-1009.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2010, 756, 8105-8109.